vs
EVI INDUSTRIES, INC.（EVI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
EVI INDUSTRIES, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$115.3M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 2.1%，领先382.0%），EVI INDUSTRIES, INC.同比增速更快（24.4% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 17.2%）
EVI Industries是一家商用洗衣、干洗及衣物护理设备的领先分销商，主要服务北美市场，客户涵盖自助洗衣店、酒店、医疗机构及多户住宅物业，同时提供设备安装、维护及售后支持服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
EVI vs RIGL — 直观对比
营收规模更大
EVI
是对方的1.7倍
$69.8M
营收增速更快
EVI
高出3.2%
21.2%
净利率更高
RIGL
高出382.0%
2.1%
两年增速更快
RIGL
近两年复合增速
17.2%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.3M | $69.8M |
| 净利润 | $2.4M | $268.1M |
| 毛利率 | 30.8% | 91.5% |
| 营业利润率 | 3.7% | 33.2% |
| 净利率 | 2.1% | 384.0% |
| 营收同比 | 24.4% | 21.2% |
| 净利润同比 | 109.9% | 1769.2% |
| 每股收益（稀释后） | $0.15 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVIRIGL
| Q4 25 | $115.3M | $69.8M | ||
| Q3 25 | $108.3M | $69.5M | ||
| Q2 25 | $110.0M | $101.7M | ||
| Q1 25 | $93.5M | $53.3M | ||
| Q4 24 | $92.7M | $57.6M | ||
| Q3 24 | $93.6M | $55.3M | ||
| Q2 24 | $90.1M | $36.8M | ||
| Q1 24 | $84.0M | $29.5M |
净利润EVIRIGL
| Q4 25 | $2.4M | $268.1M | ||
| Q3 25 | $1.8M | $27.9M | ||
| Q2 25 | $2.1M | $59.6M | ||
| Q1 25 | $1.0M | $11.4M | ||
| Q4 24 | $1.1M | $14.3M | ||
| Q3 24 | $3.2M | $12.4M | ||
| Q2 24 | $2.1M | $-1.0M | ||
| Q1 24 | $956.0K | $-8.2M |
毛利率EVIRIGL
| Q4 25 | 30.8% | 91.5% | ||
| Q3 25 | 31.3% | 93.2% | ||
| Q2 25 | 30.8% | 95.6% | ||
| Q1 25 | 30.0% | 91.7% | ||
| Q4 24 | 29.7% | 89.9% | ||
| Q3 24 | 30.8% | 85.5% | ||
| Q2 24 | 30.4% | 92.4% | ||
| Q1 24 | 30.7% | 93.1% |
营业利润率EVIRIGL
| Q4 25 | 3.7% | 33.2% | ||
| Q3 25 | 3.3% | 40.9% | ||
| Q2 25 | 3.7% | 60.1% | ||
| Q1 25 | 2.4% | 23.9% | ||
| Q4 24 | 2.6% | 28.9% | ||
| Q3 24 | 5.3% | 25.4% | ||
| Q2 24 | 4.1% | 1.2% | ||
| Q1 24 | 2.9% | -23.6% |
净利率EVIRIGL
| Q4 25 | 2.1% | 384.0% | ||
| Q3 25 | 1.7% | 40.2% | ||
| Q2 25 | 1.9% | 58.6% | ||
| Q1 25 | 1.1% | 21.5% | ||
| Q4 24 | 1.2% | 24.9% | ||
| Q3 24 | 3.5% | 22.5% | ||
| Q2 24 | 2.3% | -2.8% | ||
| Q1 24 | 1.1% | -27.9% |
每股收益（稀释后）EVIRIGL
| Q4 25 | $0.15 | $14.11 | ||
| Q3 25 | $0.11 | $1.46 | ||
| Q2 25 | $0.14 | $3.28 | ||
| Q1 25 | $0.07 | $0.63 | ||
| Q4 24 | $0.07 | $0.82 | ||
| Q3 24 | $0.21 | $0.70 | ||
| Q2 24 | $0.13 | $-0.06 | ||
| Q1 24 | $0.06 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $144.0M | $391.5M |
| 总资产 | $315.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资EVIRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | $4.7M | $137.1M | ||
| Q2 25 | $8.9M | $108.4M | ||
| Q1 25 | $5.9M | $77.1M | ||
| Q4 24 | $3.9M | $77.3M | ||
| Q3 24 | $4.4M | $61.1M | ||
| Q2 24 | $4.6M | $49.1M | ||
| Q1 24 | $3.3M | $49.5M |
总债务EVIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | $24.0M | $60.0M | ||
| Q4 24 | $27.9M | $60.0M | ||
| Q3 24 | $19.9M | $60.0M | ||
| Q2 24 | $12.9M | $60.0M | ||
| Q1 24 | $21.9M | $60.0M |
股东权益EVIRIGL
| Q4 25 | $144.0M | $391.5M | ||
| Q3 25 | $140.8M | $117.6M | ||
| Q2 25 | $143.5M | $81.9M | ||
| Q1 25 | $140.2M | $18.6M | ||
| Q4 24 | $138.0M | $3.3M | ||
| Q3 24 | $136.1M | $-14.6M | ||
| Q2 24 | $136.6M | $-29.9M | ||
| Q1 24 | $133.5M | $-31.7M |
总资产EVIRIGL
| Q4 25 | $315.6M | $513.6M | ||
| Q3 25 | $321.8M | $242.5M | ||
| Q2 25 | $307.0M | $206.7M | ||
| Q1 25 | $251.8M | $176.0M | ||
| Q4 24 | $248.8M | $164.0M | ||
| Q3 24 | $245.5M | $139.4M | ||
| Q2 24 | $230.7M | $128.4M | ||
| Q1 24 | $239.3M | $126.5M |
负债/权益比EVIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | 0.17× | 3.23× | ||
| Q4 24 | 0.20× | 18.25× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.70× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EVIRIGL
| Q4 25 | $4.0M | $22.0M | ||
| Q3 25 | $1.0M | $24.0M | ||
| Q2 25 | $9.9M | $30.5M | ||
| Q1 25 | $9.1M | $-893.0K | ||
| Q4 24 | $2.0M | $14.5M | ||
| Q3 24 | $207.0K | $21.7M | ||
| Q2 24 | $12.4M | $302.0K | ||
| Q1 24 | $9.4M | $-5.0M |
自由现金流EVIRIGL
| Q4 25 | — | — | ||
| Q3 25 | $-890.0K | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-1.0M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $8.1M | — |
自由现金流率EVIRIGL
| Q4 25 | — | — | ||
| Q3 25 | -0.8% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | -1.1% | — | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 9.7% | — |
资本支出强度EVIRIGL
| Q4 25 | — | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 1.5% | — |
现金转化率EVIRIGL
| Q4 25 | 1.70× | 0.08× | ||
| Q3 25 | 0.55× | 0.86× | ||
| Q2 25 | 4.74× | 0.51× | ||
| Q1 25 | 8.79× | -0.08× | ||
| Q4 24 | 1.74× | 1.01× | ||
| Q3 24 | 0.06× | 1.75× | ||
| Q2 24 | 5.99× | — | ||
| Q1 24 | 9.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
